Collaboration will support Australia with direct access to rapid pandemic response capabilities “We are excited to expand our presence and continue our long-term collaboration with the Australian and ...

While U.S. policymakers are scaling back funding on mRNA vaccine research, Australia is accelerating investment in the technology. At the center of this effort is Moderna Inc., which is establishing ...

CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked as a top employer in the global biopharmaceutical industry in Science and Science Careers ...

Company to discontinue development of mRNA-1647 in congenital CMV Company will continue to evaluate mRNA-1647 in ongoing Phase 2 trial in bone marrow transplant patients Company does not anticipate ...

Vaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in the U.S. and Australia. Back To Top ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA platform to treat or prevent diseases such as cancer. They did not include ...